Clinical evaluation of presepsin considering renal function

• Published in: PloS one 2019-09, Vol.14 (9), p.e0215791-e0215791
• Main Authors: Miyoshi, Masashi, Inoue, Yusuke, Nishioka, Mai, Ikegame, Akishige, Nakao, Takayuki, Kishi, Seiji, Doi, Toshio, Nagai, Kojiro
• Format: Article
• Language: English
• Subjects: Adult; Aged; Bacterial diseases; Bacterial infections; Bioindicators; Biological markers; Biology and Life Sciences; Biomarkers; Biomarkers - blood; Blood; Blood banks; Chronic kidney failure; Creatinine; Creatinine - blood; Cystatins - blood; Diagnosis; EDTA; Ethylenediaminetetraacetic acids; Evaluation; Female; Glomerular Filtration Rate; Glycoproteins; Humans; Infection; Infections; Intensive care; Kidney - physiopathology; Kidney diseases; Kidneys; Laboratories; Lipopolysaccharide Receptors - blood; Male; Medical technology; Medicine and Health Sciences; Middle Aged; Nephrology; Peptide Fragments - blood; Phagocytosis; Proteins; Renal function; Renal Insufficiency, Chronic - blood; Renal Insufficiency, Chronic - diagnosis; Risk factors; Sepsis; Stirring; Systematic review; Transplants & implants
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0215791

Presepsin, a glycoprotein produced during bacterial phagocytosis, is used as a sepsis marker for bacterial infections. However, presepsin levels are affected by renal function, and the evaluation criteria according to kidney function or in chronic kidney diseases remain controversial. Furthermore, presepsin may be increased by sample stirring, but no studies have evaluated this effect.In this study, we excluded the effect of stirring by standardizing the blood collection conditions, analyzed the influence of kidney function on presepsin concentrations, and recalculated the reference range based on the findings. EDTA-whole blood from 47 healthy subjects and 85 patients with chronic kidney disease was collected to measure presepsin by PATHFAST. Presepsin was found to be significantly correlated with the levels of creatinine (r = 0.834), eGFRcreat (r = 0.837), cystatin-C (r = 0.845), and eGFRcys (r = 0.879). Furthermore, in patients with CKD, presepsin levels stratified by eGFRcys showed a significant increase in the CKD G2 patient group and with advancing glomerular filtration rate stage. The following values were obtained: Normal: 97.6 ± 27.4 pg/mL, CKD G1: 100.2 ± 27.6 pg/mL, CKD G2: 129.7 ± 40.7 pg/mL, CKD G3: 208.1 ± 70.2 pg/mL, CKD G4: 320.2 ± 170.1 pg/mL, CKD G5: 712.8 ± 336.3 pg/mL. The reference range, calculated by a nonparametric method using 67 cases of healthy volunteers and patients with chronic kidney disease G1, was found to be 59-153 pg/mL, which was notably lower than the standard reference range currently used. Presepsin concentrations were positively correlated with a few biomarkers of renal function, indicating the necessity to consider the effect of renal function in patients with renal impairment. Using the recalculated reference range considering kidney function may improve the accuracy of evaluating presepsin for diagnosis of sepsis compared to the standard reference currently in use.